Evidence map›Paper›PMID 34298174›Full record

ArticleTravel medicine and infectious disease

Limited capacity of SARS-CoV-2 variants testing in Japan: A secondary analysis using publicly available data.

Takanao Hashimoto, Akihiko Ozaki, Divya Bhandari, Toyoaki Sawano, Anju Murayama, Sunil Shrestha, Ranjit Sah, Tetsuya Tanimoto, Juan J Montenegro-Idrogo, Alfonso J Rodriguez-Morales

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takanao HashimotoDepartment of Pharmacy, Sendai City Medical Center, Sendai, Miyagi, Japan.
Akihiko OzakiDepartment of Breast Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan; Medical Governance Research Institute, Tokyo, Japan.
Divya BhandariMedical Governance Research Institute, Tokyo, Japan.
Toyoaki SawanoDepartment of Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.
Anju MurayamaMedical Governance Research Institute, Tokyo, Japan.
Sunil ShresthaSchool of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500, Bandar Sunway, Selangor Darul Ehsan, Malaysia.
Ranjit SahTribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
Tetsuya TanimotoNavitas Clinic Kawasaki, Kanagawa, Japan.
Juan J Montenegro-IdrogoService of Infectious and Tropical Diseases, Hospital Nacional Dos de Mayo, Lima, Peru; Master in Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima, Peru.
Alfonso J Rodriguez-MoralesMaster in Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima, Peru; Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Américas, Pereira, Colombia; Universidad Privada Franz Tamayo, Cochabamba, Bolivia. Electronic address: arodriguezmo@cientifica.edu.pe.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2HumansJapanReal-Time Polymerase Chain ReactionJapanPandemicPolymerase chain reactionSARS-CoV-2Variants

Identifiers

PMID34298174
PMCPMC8294103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.